FABP4 and gastric adenocarcinoma: The low-expression group of FABP4 in STAD had a better prognosis (OS: HR = 1.72, log-rank p = 0.0012, RFS: HR = 2.93, log-rank p = 0.0033) (Figure 3(c)).